The circulating level of soluble tumor necrosis factor receptor 2 (sTNFR2), which is released from the cell surface, is associated with end-stage renal disease, cardiovascular disease, and mortality in patients with type 2 diabetes [10–13]. Here, TNFRSF1B is linked to type 2 diabetes mellitus.